Psychiatric Comorbidities in Chronic Spontaneous Urticaria: An Overlooked Dimension
Indian Dermatology Online Journal · 2026-11 · 17 (6) · 895-898
DOI: 10.4103/idoj.idoj_339_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Dermatology Online Journal, online erschienen am 28.05.2026. Verfasst von Muthu Sendhil Kumaran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Chronic spontaneous urticaria (CSU) is marked by recurrent wheals with or without angioedema, often without clear triggers. While its physical burden is well known, the psychological impact - particularly anxiety, depression, and sleep disturbances are underrecognized. Literature reports significant psychiatric comorbidities and even suicidal ideation in CSU patients, likely linked through neuroimmune pathways such as hypothalamic–pituitary–adrenal (HPA) axis dysregulation.[1] However, Indian data remain sparse, largely limited to small, hospital-based studies, which may not reflect the broader population. This narrative review aims to consolidate the existing evidence on psychiatric comorbidities in CSU, elucidates the underlying neuroimmune mechanisms, examine their impact on quality of life, and advocate for a holistic, multidisciplinary management approach. While the current literature is predominantly Western, this narrative review highlights the need for India-specific studies to guide culturally relevant psycho-dermatological care. Methodology A comprehensive search strategy was employed to retrieve relevant literature from PubMed, Embase, Scopus, and Google Scholar. The search terms included “chronic spontaneous urticaria,” “psychiatric comorbidities,” “anxiety,” “depression,” “quality of life,” and “disease severity.” Boolean operators (AND/OR) were used to refine search results, and filters were applied to include only studies published in English. Reference lists of key articles were manually screened to identify additional relevant studies. Neuro- cutaneous embryonic link The skin and central nervous system originates from the embryonic ectoderm, forming the basis for a neuro-immuno-cutaneous axis through which psychological stress can influence cutaneous diseases. This is particularly evident in CSU, where bidirectional communication between the brain, immune system, and skin sustains disease chronicity. Psychological stress activates the HPA axis and sympathetic-adrenal-medullary system, initially increasing cortisol and catecholamine levels. However, chronic stress leads to HPA axis hypoactivity, with cortisol suppression and upregulation of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α), key mediators of mast cell degranulation in CSU.[2] Concurrently, stress-induced disruption of the tryptophan–kynurenine pathway reduces serotonin synthesis and accumulates neurotoxic metabolites, contributing to mood disturbances frequently observed in CSU.[1] Zhao et al.[3] identified altered connectivity in the anterior cingulate cortex, insula, and prefrontal cortex, the regions involved in emotion and itch processing, correlating with symptom severity. Yang et al.[2] further defined CSU as a neuroinflammatory disorder driven by sensory neuron–mast cell–cytokine–brain crosstalk, advocating neuro-modulatory therapies. Prevalence of psychiatric comorbidities in chronic spontaneous urticaria Psychiatric comorbidities are among the most significant yet often overlooked aspects of CSU. The estimated prevalence of CSU in general population ranges between 0.5% and 5% and psychiatric comorbidities in them are significantly common, with overall prevalence estimated at 31.61%. A latest systematic review and meta-analysis demonstrated that approximately one in three patients with CSU have at least one psychiatric comorbidity. According to the diagnostic and statistical manual of mental disorders fifth edition (DSM-5) classification, sleep-wake disorders (36.7%) are commonest, followed by anxiety disorders (30.6%), mood disorders (29.4%), trauma- and stressor-related disorders (17.3%), somatic symptom-related disorders (17.2%), obsessive-compulsive disorders (9.3%), and substance use and addictive disorders (4%).[4] In an observational cohort of 2,579 dermatology outpatients, 29 patients were diagnosed with CSU, of whom 34.5% had an associated psychiatric disorder. In a separate study conducted by the same group on 466 dermatology patients, 85 were identified as having CSU, and 16 of these patients (18.8%) reported suicidal ideation.[4] Mehta et al.[5] analyzed 50 CSU patients and found that depression (30%) was commonest psychiatric comorbidity, followed by suicidality (12%), panic disorder (4%), obsessive–compulsive disorder (2%), and alcohol abuse, dependence, psychotic disorders, and mood disorders with psychotic features (2%). Similarly, Staubach et al.[6] evaluated 100 CSU patients and reported that 48% had at least one psychiatric disorder, with anxiety (30%), depressive disorders (17%), and somatoform disorders (17%) being the most frequently observed. Later, same authors compared 100 CSU patients with 96 healthy controls, revealing that 48% of CSU patients suffered from at least one psychiatric disorder, further emphasizing the disease’s psychological impact.[7] Other studies reflecting similar results have been depicted in Figure 1. Suicidal ideation has been documented in patients with chronic spontaneous urticaria in multiple clinical studies, emphasizing the need for routine psychological assessment as part of comprehensive CSU care. Picardi et al. found an 18.8% prevalence of suicidal ideation in CSU patients, while Mehta et al. reported a prevalence of 12%.[4,5] However, these data are institution and hospital-based rather than population-representative, highlighting a potential risk but not supporting a generalized assumption applicable to all CSU populations. These figures may not reflect Indian prevalence as dermatological services are stratified across various levels of healthcare and many cases of mild urticaria are managed in primary care or through self-medication, thereby leading to a conspicuous paucity of population-based data. Data from Indian studies are summarized in Table 1.Figure 1: Shows findings of various studies presenting psychiatric comorbidities in chronic spontaneous urticaria patients. CSU = Chronic Spontaneous UrticariaTable 1: Summary of Indian studies on psychiatric comorbidities in chronic spontaneous urticariaImpact of psychiatric co-morbidities on quality of life (QoL) in urticaria CSU significantly impairs the quality of life (QoL), with emotional and functional disturbances often exceeding physical symptoms. Staubach et al., using the skindex-29 questionnaire, reported markedly reduced QoL in CSU patients, primarily due to psychiatric comorbidities rather than clinical factors like age, sex, or disease duration. Depression, anxiety, and somatoform disorders were key predictors of QoL decline, with disease severity correlating with greater impairment. Tools like hospital anxiety and depression scale (HADS) and screening for somatoform symptoms (SOMS) are recommended for identifying psychological distress.[6,7] Zuberbier et al.,[12] in the European academy of allergology and clinical immunology (EAACI)/Global allergy and asthma European network (GA²LEN)/European dermatology forum (EDF) urticaria guidelines, emphasized the profound psychosocial burden of chronic urticaria, noting that its impact on health-related quality of life (HRQoL) rivals that of serious systemic diseases. They endorsed the chronic urticaria quality of life questionnaire (CSU-Q2oL) as a validated tool for assessing disease-specific physical, emotional, and social impairment. Although mood disorders were not directly addressed, tricyclic antidepressants like doxepin were listed as adjunctive options in refractory cases. This emphasizes the need for integrated psychological evaluation in CSU management. Management The management of CSU necessitates an integrated approach involving dermatological, neuropsychiatric, and lifestyle interventions due to its complex neuroimmune pathophysiology.[2] Emerging therapies target inflammation, neural dysregulation, and psychological stress. Apart from routine treatment, psychiatric interventions have shown efficacy in refractory CSU cases [Table 2]. Psychological therapies like cognitive behavioral therapy, acceptance and commitment therapy, and mindfulness techniques reduce stress-induced disease flare-ups. Neuropsychiatric agents like selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants offer dual benefits, mood stabilization and anti-inflammatory effects. Melatonin, with immunomodulatory and sleep-regulating properties, may also aid CSU management.[2]Table 2: Evidence of psychiatric intervention showing improvement in resistant chronic spontaneous urticaria casesLifestyle modifications, including yoga, meditation, and regular exercise, help reduce stress-related mast cell activation and neuroinflammation. Updated CSU treatment guidelines recommend higher-dose antihistamines for refractory cases, alongside biologics such as omalizumab, dupilumab, and Janus kinase inhibitors targeting mast cell and neuroimmune pathways.[4] Neuropeptide antagonists inhibiting substance-P and calcitonin gene-related peptide represent another promising strategy, highlighting the evolving role of neuroimmune modulation in CSU therapy.[4] With growing insight into neuroimmune interactions, personalized therapies targeting individual neuroimmune profiles hold promise. Identifying relevant biomarkers may aid in tailored treatment. As psychological stress plays a key role in CSU exacerbations, integrating stress management techniques and psychological support along with standard of care for CSU can improve outcomes.
Conclusion
This review highlights the underrecognized psychiatric dimension of CSU, and identify critical research gaps especially in the Indian context. Hence, there is a need for multi-centric, population-based studies to better understand the psycho-dermatological impact of CSU within our socio-cultural framework. Authors’ contributions We confirm that all authors have read and approved the manuscript for submission. All authors meet authorship criteria, and the manuscript represents honest work. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest. Use of artificial intelligence (AI) The authors state that artificial intelligence has not been used in preparation of any part of this manuscript.
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Zitieren
APA
Kumaran, M. S., Kaur, S., & Narang, T. (2026). Psychiatric Comorbidities in Chronic Spontaneous Urticaria: An Overlooked Dimension. Indian Dermatology Online Journal, 17(6), 895-898. https://doi.org/10.4103/idoj.idoj_339_25
Vancouver
Kumaran MS, Kaur S, Narang T. Psychiatric Comorbidities in Chronic Spontaneous Urticaria: An Overlooked Dimension. Indian Dermatology Online Journal. 2026;17(6):895-898. doi:10.4103/idoj.idoj_339_25
BibTeX
@article{Kumaran2026,
author = {Kumaran, Muthu Sendhil and Kaur, Sahibpreet and Narang, Tarun},
title = {Psychiatric Comorbidities in Chronic Spontaneous Urticaria: An Overlooked Dimension},
journal = {Indian Dermatology Online Journal},
year = {2026},
volume = {17},
number = {6},
pages = {895--898},
doi = {10.4103/idoj.idoj_339_25}
}
EUVIMED